Ai Day 1 Llc - Net Worth and Insider Trading

Ai Day 1 Llc Net Worth

The estimated net worth of Ai Day 1 Llc is at least $88 Million dollars as of 2025-07-04. Ai Day 1 Llc is the 10% Owner of Day One Biopharmaceuticals Inc and owns about 12,929,322 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $88 Million. Details can be seen in Ai Day 1 Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ai Day 1 Llc has not made any transactions after 2023-10-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Ai Day 1 Llc

To

Ai Day 1 Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ai Day 1 Llc owns 1 companies in total, including Day One Biopharmaceuticals Inc (DAWN) .

Click here to see the complete history of Ai Day 1 Llc’s form 4 insider trades.

Insider Ownership Summary of Ai Day 1 Llc

Ticker Company Transaction Date Type of Owner
DAWN Day One Biopharmaceuticals Inc 2023-10-20 10 percent owner

Ai Day 1 Llc Latest Holdings Summary

Ai Day 1 Llc currently owns a total of 1 stock. Ai Day 1 Llc owns 12,929,322 shares of Day One Biopharmaceuticals Inc (DAWN) as of October 20, 2023, with a value of $88 Million.

Latest Holdings of Ai Day 1 Llc

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DAWN Day One Biopharmaceuticals Inc 2023-10-20 12,929,322 6.80 87,919,390

Holding Weightings of Ai Day 1 Llc


Ai Day 1 Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Ai Day 1 Llc has made a total of 4 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the acquisition of 1,475,454 shares on October 20, 2023, which cost Ai Day 1 Llc around $15 Million.

Insider Trading History of Ai Day 1 Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ai Day 1 Llc Trading Performance

GuruFocus tracks the stock performance after each of Ai Day 1 Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ai Day 1 Llc is 16.21%. GuruFocus also compares Ai Day 1 Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ai Day 1 Llc within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ai Day 1 Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ai Day 1 Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.1 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.07 LIMIT LIMIT LIMIT LIMIT LIMIT

Ai Day 1 Llc Ownership Network

Ownership Network List of Ai Day 1 Llc

No Data

Ownership Network Relation of Ai Day 1 Llc

Insider Network Chart


Ai Day 1 Llc Owned Company Details

What does Day One Biopharmaceuticals Inc do?

Who are the key executives at Day One Biopharmaceuticals Inc?

Ai Day 1 Llc is the 10 percent owner of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include COO & CFO and Secretary York Charles N Ii , director & Chief Executive Officer Jeremy Bender , and Chief Medical Officer Samuel C. Blackman .

Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary

Over the past 18 months, Ai Day 1 Llc made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 238,963 shares made by Samuel C. Blackman , a net sale of 141,946 shares made by Jeremy Bender , and a net sale of 79,689 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 26,725 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 26,725 shares. During the past 18 months, 496,585 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 496,585 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Day One Biopharmaceuticals Inc Insider Transactions

No Available Data

Ai Day 1 Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Ai Day 1 Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ai Day 1 Llc's mailing address is: New York Ny 10019.